Biodexa Pharmaceuticals PLC Unsponsored ADR (NASDAQ:BDRX) Short Interest Update

Biodexa Pharmaceuticals PLC Unsponsored ADR (NASDAQ:BDRX) was the recipient of a large increase in short interest in the month of September. As of September 15th, there was short interest totaling 13,500 shares, an increase of 214.0% from the August 31st total of 4,300 shares. Based on an average daily volume of 69,700 shares, the short-interest ratio is currently 0.2 days. Based on an average daily volume of 69,700 shares, the short-interest ratio is currently 0.2 days.

Biodexa Pharmaceuticals Trading Up 0.9%

Shares of Biodexa Pharmaceuticals stock opened at $6.67 on Friday. The company has a 50-day simple moving average of $6.58 and a 200 day simple moving average of $10.42. Biodexa Pharmaceuticals has a 12-month low of $5.00 and a 12-month high of $108.90.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen downgraded shares of Biodexa Pharmaceuticals from a “hold” rating to a “strong sell” rating in a report on Saturday, August 2nd.

About Biodexa Pharmaceuticals

Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes.